Evidence map›Paper›PMID 33362481›Full record

ArticleFrontiers in neuroanatomy2020

Spatiotemporal Up-Regulation of Mu Opioid Receptor 1 in Striatum of Mouse Model of Huntington's Disease Differentially Affecting Caudal and Striosomal Regions.

Ryoma Morigaki, Jannifer H Lee, Tomoko Yoshida, Christian Wüthrich, Dan Hu, Jill R Crittenden, Alexander Friedman, Yasuo Kubota, Ann M Graybiel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroanatomy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Striosome Circuitry Stimulation Inhibits Striatal Dopamine Release and Locomotion.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ryoma MorigakiMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Jannifer H LeeMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Tomoko YoshidaMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Christian WüthrichMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Dan HuMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Jill R CrittendenMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Alexander FriedmanMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Yasuo KubotaMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Ann M GraybielMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Massachusetts Institute of Technology · USMcGovern Institute for Brain Research · USJacksonville College · USTokushima University · JP

Funding

Functional and anatomical characterization of the striosomal systemR01MH060379 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Ann M Graybiel · 2000 to 2026
$8.7M
NIMH NIH HHS R01 MH060379
6 · The paper itself

Abstract

The striatum of humans and other mammals is divided into macroscopic compartments made up of a labyrinthine striosome compartment embedded in a much larger surrounding matrix compartment. Anatomical and snRNA-Seq studies of the Huntington's disease (HD) postmortem striatum suggest a preferential decline of some striosomal markers, and mRNAs studies of HD model mice concur. Here, by immunohistochemical methods, we examined the distribution of the canonical striosomal marker, mu-opioid receptor 1 (MOR1), in the striatum of the Q175 knock-in mouse model of HD in a postnatal time series extending from 3 to 19 months. We demonstrate that, contrary to the loss of many markers for striosomes, there is a pronounced up-regulation of MOR1 in these Q175 knock-in mice. We show that in heterozygous Q175 knock-in model mice [~192 cytosine-adenine-guanine (CAG) repeats], this MOR1 up-regulation progressed with advancing age and disease progression, and was particularly remarkable at caudal levels of the striatum. Given the known importance of MOR1 in basal ganglia signaling, our findings, though in mice, should offer clues to the pathogenesis of psychiatric features, especially depression, reinforcement sensitivity, and involuntary movements in HD.

Indexed as

animal models of human disordersHuntington’s diseasemood disordersmovement disordersmu opioid receptorsneostriatumstriosome

Identifiers

PMID33362481
PMCPMC7758501
OpenAlexW3111136394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.